140 related articles for article (PubMed ID: 22363056)
1. Tissue factor pathway inhibitor, activated protein C resistance, and risk of ischemic stroke due to postmenopausal hormone therapy.
Rossouw JE; Johnson KC; Pettinger M; Cushman M; Sandset PM; Kuller L; Rosendaal F; Rosing J; Wasserthal-Smoller S; Martin LW; Manson JE; Lakshminarayan K; Merino JG; Lynch J
Stroke; 2012 Apr; 43(4):952-7. PubMed ID: 22363056
[TBL] [Abstract][Full Text] [Related]
2. Lipoprotein-associated phospholipase A2, hormone use, and the risk of ischemic stroke in postmenopausal women.
Wassertheil-Smoller S; Kooperberg C; McGinn AP; Kaplan RC; Hsia J; Hendrix SL; Manson JE; Berger JS; Kuller LH; Allison MA; Baird AE
Hypertension; 2008 Apr; 51(4):1115-22. PubMed ID: 18259035
[TBL] [Abstract][Full Text] [Related]
3. Lipid and lipoprotein biomarkers and the risk of ischemic stroke in postmenopausal women.
Berger JS; McGinn AP; Howard BV; Kuller L; Manson JE; Otvos J; Curb JD; Eaton CB; Kaplan RC; Lynch JK; Rosenbaum DM; Wassertheil-Smoller S
Stroke; 2012 Apr; 43(4):958-66. PubMed ID: 22308251
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte growth factor and the risk of ischemic stroke developing among postmenopausal women: results from the Women's Health Initiative.
Rajpathak SN; Wang T; Wassertheil-Smoller S; Strickler HD; Kaplan RC; McGinn AP; Wildman RP; Rosenbaum D; Rohan TE; Scherer PE; Cushman M; Ho GY
Stroke; 2010 May; 41(5):857-62. PubMed ID: 20203323
[TBL] [Abstract][Full Text] [Related]
5. Serum fatty acids and incidence of ischemic stroke among postmenopausal women.
Yaemsiri S; Sen S; Tinker LF; Robinson WR; Evans RW; Rosamond W; Wasserthiel-Smoller S; He K
Stroke; 2013 Oct; 44(10):2710-7. PubMed ID: 23899914
[TBL] [Abstract][Full Text] [Related]
6. High-molecular-weight adiponectin and incident ischemic stroke in postmenopausal women: a Women's Health Initiative Study.
Ogorodnikova AD; Wassertheil-Smoller S; Mancuso P; Sowers MR; Rajpathak SN; Allison MA; Baird AE; Rodriguez B; Wildman RP
Stroke; 2010 Jul; 41(7):1376-81. PubMed ID: 20508194
[TBL] [Abstract][Full Text] [Related]
7. Venous thrombosis with oral postmenopausal hormone therapy: Roles of activated protein C resistance and tissue factor pathway inhibitor.
Khialani D; Vasan S; Cushman M; Dahm AEA; Sandset PM; Rossouw J; van Hylckama Vlieg A
J Thromb Haemost; 2021 Jul; 19(7):1729-1737. PubMed ID: 33774921
[TBL] [Abstract][Full Text] [Related]
8. Tissue Factor Pathway Inhibitor, Activated Protein C Resistance, and Risk of Coronary Heart Disease Due To Combined Estrogen Plus Progestin Therapy.
Johnson KC; Aragaki AK; Jackson R; Reiner A; Sandset PM; Rosing J; Dahm AE; Rosendaal F; Manson JE; Martin LW; Liu S; Kuller LH; Cushman M; Rossouw JE
Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):418-24. PubMed ID: 26681757
[TBL] [Abstract][Full Text] [Related]
9. Plasma Estradiol and Testosterone Levels and Ischemic Stroke in Postmenopausal Women.
Hu J; Lin JH; Jiménez MC; Manson JE; Hankinson SE; Rexrode KM
Stroke; 2020 Apr; 51(4):1297-1300. PubMed ID: 32078496
[TBL] [Abstract][Full Text] [Related]
10. Effect of long-term hormone replacement therapy on tissue factor pathway inhibitor and thrombin activatable fibrinolysis inhibitor in healthy postmenopausal women: a randomized controlled study.
Bladbjerg EM; Madsen JS; Kristensen SR; Abrahamsen B; Brixen K; Mosekilde L; Jespersen J
J Thromb Haemost; 2003 Jun; 1(6):1208-14. PubMed ID: 12871321
[TBL] [Abstract][Full Text] [Related]
11. Effect of oral and transdermal estrogen replacement therapy on hemostatic variables associated with venous thrombosis: a randomized, placebo-controlled study in postmenopausal women.
Post MS; Christella M; Thomassen LG; van der Mooren MJ; van Baal WM; Rosing J; Kenemans P; Stehouwer CD
Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):1116-21. PubMed ID: 12730085
[TBL] [Abstract][Full Text] [Related]
12. The effect of different hormonal contraceptives on plasma levels of free protein S and free TFPI.
Raps M; Helmerhorst FM; Fleischer K; Dahm AE; Rosendaal FR; Rosing J; Reitsma P; Sandset PM; van Vliet HA
Thromb Haemost; 2013 Apr; 109(4):606-13. PubMed ID: 23407778
[TBL] [Abstract][Full Text] [Related]
13. Effect of raloxifene on activated protein C (APC) resistance in postmenopausal women and on APC resistance and homocysteine levels in elderly men: two randomized placebo-controlled studies.
Duschek EJ; Neele SJ; Thomassen MC; Rosing J; Netelenbos C
Blood Coagul Fibrinolysis; 2004 Oct; 15(8):649-55. PubMed ID: 15613919
[TBL] [Abstract][Full Text] [Related]
14. Decreased plasma tissue factor pathway inhibitor activity in ischemic stroke patients.
Abumiya T; Yamaguchi T; Terasaki T; Kokawa T; Kario K; Kato H
Thromb Haemost; 1995 Oct; 74(4):1050-4. PubMed ID: 8560412
[TBL] [Abstract][Full Text] [Related]
15. Tissue factor pathway inhibitor polymorphisms in women with and without a history of venous thrombosis and the effects of postmenopausal hormone therapy.
Opstad TB; Eilertsen AL; Høibraaten E; Skretting G; Sandset PM
Blood Coagul Fibrinolysis; 2010 Sep; 21(6):516-21. PubMed ID: 20453636
[TBL] [Abstract][Full Text] [Related]
16. Hormone replacement therapy and acquired resistance to activated protein C: results of a randomized, double-blind, placebo-controlled trial.
Høibraaten E; Mowinckel MC; de Ronde H; Bertina RM; Sandset PM
Br J Haematol; 2001 Nov; 115(2):415-20. PubMed ID: 11703344
[TBL] [Abstract][Full Text] [Related]
17. Increased resistance to activated protein C after short-term oral hormone replacement therapy in healthy post-menopausal women.
Post MS; Rosing J; Van Der Mooren MJ; Zweegman S; Van Baal WM; Kenemans P; Stehouwer CD;
Br J Haematol; 2002 Dec; 119(4):1017-23. PubMed ID: 12472583
[TBL] [Abstract][Full Text] [Related]
18. Walking speed and risk of incident ischemic stroke among postmenopausal women.
McGinn AP; Kaplan RC; Verghese J; Rosenbaum DM; Psaty BM; Baird AE; Lynch JK; Wolf PA; Kooperberg C; Larson JC; Wassertheil-Smoller S
Stroke; 2008 Apr; 39(4):1233-9. PubMed ID: 18292379
[TBL] [Abstract][Full Text] [Related]
19. Hormone replacement therapy and associated risk of stroke in postmenopausal women.
Lemaitre RN; Heckbert SR; Psaty BM; Smith NL; Kaplan RC; Longstreth WT
Arch Intern Med; 2002 Sep; 162(17):1954-60. PubMed ID: 12230417
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effects of postmenopausal hormone replacement therapy with transdermal estradiol on sensitivity to activated protein C.
De Mitrio V; Marino R; Cicinelli E; Galantino P; Di Bari L; Giannoccaro F; De Pergola G; Lapecorella M; Schonauer S; Schiraldi O
Blood Coagul Fibrinolysis; 2000 Mar; 11(2):175-82. PubMed ID: 10759011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
